comprehensive -WSS

comprehensive

author：fashion 2025-09-29 21:26:00 - browse：18

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Chris Christie meets with Zelenskyy during Ukraine trip

focus

WSS

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

How a small hospital in rural Puerto Rico survived Hurricane Maria

Lawmakers grill UnitedHealth CEO on Change cyberattack

Chris Christie meets with Zelenskyy during Ukraine trip

Group behind ProMed defends move to subscription

Late stage cancers on the rise after pandemic delayed screenings

entertainment

comprehensive

explore

In age of alternative facts, a scholarly course on calling out crap

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Virginia high school admissions case could be legal follow

HHS's proposed rule does nothing to address the climate crisis

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Chris Christie meets with Zelenskyy during Ukraine trip

The high cost of giving birth even with insurance

Sepsis can kill a child within hours. Here's how hospitals are fighting back

23andMe had bad news about my health. I wish a person had delivered it

2 officers injured in shooting in Orlando, police say

explore

Crowdfunding for medical bills sidesteps core problem, author says

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

How a small hospital in rural Puerto Rico survived Hurricane Maria

Black vets could get higher VA benefits if race not used in lung test

Pharma showers House GOP doctor with campaign cash

As health system earnings go up, health insurance stocks go down

Wikipedia

knowledge

focus

knowledge